Home
Bausch + Lomb and Clearside Biomedical: FDA Approved XIPERE™ for Macular Edema Associated with Uveitis

Bausch + Lomb and Clearside Biomedical: FDA Approved XIPERE™ for Macular Edema Associated with Uveitis

Today’s Highlights October 25, 2021

Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™
Bausch + Lomb, a leading global eye health business of Bausch Health Companies (BHC), and Clearside Biomedical (This content is for paid subscribers.

Please click here to subscribe or here to log in.
Today’s Highlights
,
October 25, 2021

Other Articles